The federal shutdown in October left US public health and biomedical research systems reeling and exposed their vulnerability to national politics. The shutdown reduced staffing at the federal health agencies, crippling many programs and cutting off funding for health services, research laboratories, and other efforts that depend on federal support.
The interruption of public health efforts raised major concerns as the nation entered peak seasons for influenza and other communicable diseases. Troubling stories emerged in the media about hundreds of patients who could not enroll in cancer clinical trials at the National Institutes of Health (NIH) Clinical Center because new trials had been stopped (http://wapo.st/1glMSxk) and about vulnerable families at risk of losing their federal food aid (http://onforb.es/18sraDB).
Kuehn BM. Shutdown Underscored Vulnerability of US Public Health and Biomedical Research to Political Wrangling. JAMA. 2013;310(18):1907-1909. doi:10.1001/jama.2013.281654